DXSP DXS International PLC

Notice of AGM

Notice of AGM

DXS INTERNATIONAL PLC

Notice of 2022 Annual General Meeting

The Board of DXS International plc (the “Company”), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems confirms that its Annual General Meeting is scheduled to take place on Thursday 1st December 2022 at 11:30am at the Pavilion Café, Tanshire Park, Shackleford Road, Elstead, Surrey GU8 6LB.

For further information in relation to the AGM shareholders should refer to the Notice of Annual General Meeting and the AGM Letter which have been despatched to shareholders. Copies of these documents, along with the Company's Annual Report for the year ended 30 April 2022, are available for download from the Company's website .

The Directors of DXS International plc accept responsibility for this announcement

Enquiries:

David Immelman      (Chief Executive)

DXS International plc 		01252 719800

Wrecclesham House

Wrecclesham Road

Farnham

Surrey

GU10 4PS 		 
-systems.co.uk  



Corporate Advisor



  		 
David Papworth

City & Merchant 		0207 101 7676



 



Corporate Broker



  		 
Hybridan LLP

Claire Louise Noyce



  		020 3764 2341



 

Note to Editors:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.

 



EN
23/11/2022

Underlying

DXSPDXS International PLC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DXS International PLC

Hybridan Team ... (+2)
  • Hybridan Team
  • Jon Levinson
DXSP DXS Internation...

Hybridan Research: DXS International plc: Experts to Decide

DXS’s ExpertCare, a digital solution platform, is selected for the Grow Digital Health Midlands Programme. This Programme is a collaboration between Health Innovation East and West Midlands, to provide a platform to encourage digital innovation to address the NHS most pressing challenges. DXS will be exposed to the largest NHS England region, encompassing 11 Integrated Care Systems, and a population of approximately 11.8m people. The programme is designed to help UK technology innovators scale p...

DXSP DXS INTERNATIONAL PLC
06/16/25 June 16, 2025 1 EN
 PRESS RELEASE
Free
DXSP DXS Internation...

Company Update

Company Update DXS INTERNATIONAL PLC (AQSE: DXSP) ExpertCare selected for prestigious Grow Digital Health Midlands Programme DXS International plc ("DXS" or the "Company"), the digital clinical decision support company, is pleased to announce that ExpertCare, its digital medicine solution, has been selected for the prestigious Grow Digital Health Midlands Programme. Grow Digital Health Midlands - a new collaboration from Health Innovation East Midlands and Health Innovation West Midlands, has announced its first cohort of nine high-potential digital health companies of which DXS and the ...

June 10, 2025 1 EN
 PRESS RELEASE
Free
DXSP DXS Internation...

Statement re Grant of Options and Warrants

Statement re Grant of Options and Warrants DXS INTERNATIONAL PLC (AQSE: DXSP) Granting of Share Options and Warrants The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, announces that it yesterday granted share options to a number of directors, employees, and consultants. Most of these options grants are under an Enterprise Management Incentive (“EMI”) scheme and the remainder under an unapproved share option scheme. All these Share Options are at an exercise pric...

April 29, 2025 1 EN
 PRESS RELEASE
Free
DXSP DXS Internation...

Director/PDMR Shareholding

Director/PDMR Shareholding DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dealing DXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 13 February, Mr Bob Sutcliffe, the Chairman, purchased 30,000 Ordinary Shares in the Company at a price of 2.89p per share. Following this transaction Mr Sutcliffe and his wife’s interest in DXS Ordinary Shares is 1,333.756 Ordinary Shares representing 2.0...

February 14, 2025 1 EN
 PRESS RELEASE
Free
DXSP DXS Internation...

Director/PDMR Shareholding

Director/PDMR Shareholding DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dealing DXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 31 January, Mr Bob Sutcliffe, the Chairman, purchased 30,000 Ordinary Shares in the Company at a price of 2.89p per share. Following this transaction Mr Sutcliffe and his wife’s interest in DXS Ordinary Shares is 1,303.756 Ordinary Shares representing 2.04...

February 10, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch